Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesCost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria
Vaccine , 08/11/09
Zechmeister I et al. – HPV–vaccination for girls should be cost–effective when adopting a longer time–horizon and a societal perspective. Applying a shorter time frame and a payer's perspective or vaccinating boys may not be cost–effective without reducing the vaccine price.
Related Articles
Macrophage migration inhibitory factor expression in cervical cancer
Journal of Cancer Research & Clinical Oncology, 11/23/09
Relevance Score: 71%
Circulating IL-1beta levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese women
Journal of Cancer Research & Clinical Oncology, 11/23/09
Relevance Score: 69%
Clinical Outcome of Tailored Adjuvant Postoperative Chemoradiotherapy in IB FIGO Stage Cervical Cancer
Anticancer Research, 11/13/09
Relevance Score: 69%
Transvaginal doppler sonography for assessment the response to radiotherapy in locally advanced squamous cervical cancer: a preliminary study
Archives of Medical Science, 11/03/09
Relevance Score: 69%
Screening for Cancer
MedLinePlus, 11/02/09
Relevance Score: 69%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin
Current Medical Research and Opinion, 12/11/09
Economic consequences of ACS-related rehospitalizations in the US
Current Medical Research and Opinion, 12/10/09
Out-of-pocket Prices of Opioid Analgesics in the United States, 1999–2004
Pain Medicine, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor